Poonia Sukhpreet, Nguyen Mimi, Yee Anna, Eaton Melanie, Cho Robin
, BSc(Pharm), RPh, PharmD (Hons), is a Clinical Pharmacist Specialist with Community Mental Health & Substance Use Services, Fraser Health Authority, Lower Mainland Pharmacy Services, Langley, British Columbia. She is also a Clinical Instructor with the Faculty of Pharmaceutical Sciences and an Adjunct Professor with the School of Nursing (Master's Program), The University of British Columbia, Vancouver, British Columbia.
, BSc, is a candidate in the PharmD program (Class of 2025), Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia.
Can J Hosp Pharm. 2025 Aug 13;78(3):e3737. doi: 10.4212/cjhp.3737. eCollection 2025.
Clinical pharmacists play a pivotal role within collaborative care environments, with well-documented contributions on multidisciplinary teams in these settings. Their specific impacts on community mental health and substance use (MHSU) teams remains to be characterized in a publicly funded regional program within Fraser Health.
To describe the impact of medication reviews performed by clinical pharmacists and the uptake by prescribers of pharmaceutical interventions recommended by the clinical pharmacists in an ambulatory MHSU setting.
This study involved a retrospective chart review of 100 patients referred to Fraser Health Community MHSU Pharmacy Services across 20 communities within the Fraser Health Authority in British Columbia.
Clinical pharmacists identified a total of 310 drug therapy problems (DTPs) among the 100 patients. The most common DTPs identified were adverse drug reactions ( = 97, 31%), ineffective drug therapy ( = 68, 22%), unnecessary medications ( = 46, 15%), and the need for additional drug therapy ( = 35, 11%). Prescribers accepted 1 or more of the recommendations made by the clinical pharmacist in 88% (81/92) of the cases with follow-up. More than half (55%, 171/310) of the identified DTPs were resolved within 6 months of the initial pharmacist assessment.
In this study, embedding clinical pharmacists within community MHSU care teams enhanced medication safety and therapeutic optimization, while reducing polypharmacy. Future investigation into the benefits for long-term clinical outcomes is warranted.
临床药师在协作式医疗环境中发挥着关键作用,在这些环境中的多学科团队里有着充分记录的贡献。在弗雷泽健康局的一个公共资助区域项目中,他们对社区心理健康和物质使用(MHSU)团队的具体影响仍有待明确。
描述在门诊MHSU环境中,临床药师进行的药物审查的影响以及处方者对临床药师推荐的药物干预措施的采纳情况。
本研究对不列颠哥伦比亚省弗雷泽健康局内20个社区转诊至弗雷泽健康社区MHSU药房服务的100名患者进行了回顾性病历审查。
临床药师在100名患者中总共识别出310个药物治疗问题(DTPs)。识别出的最常见DTPs是药物不良反应(=97,31%)、药物治疗无效(=68,22%)、不必要的药物(=46,15%)以及需要额外的药物治疗(=35,11%)。在有随访的病例中,88%(81/92)的处方者接受了临床药师提出的1项或更多建议。超过一半(55%,171/310)的已识别DTPs在最初药师评估后的6个月内得到解决。
在本研究中把临床药师纳入社区MHSU护理团队可提高用药安全性并优化治疗,同时减少多重用药。有必要对长期临床结果的益处进行进一步研究。